Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Gene vaccine protects mice against development of Her2/neu breast cancer
February 3rd, 2005
Based on successful animal studies, a novel vaccine that uses immune cells as factories to produce Her2/neu protein may offer a way to treat some human breast cancers. The study, by researchers at The University of Texas M.D. Anderson Cancer Center, Houston, Texas, working with researchers at AlphaVax, Inc., Research Triangle Park, North Carolina, showed that the vaccine protected 86% of experimental mice against HER2/neu-associated breast cancer, even though the tumors were implanted directly into mice. The study was published recently in the online journal Breast Cancer Research. "This is an exciting strategy that seems...
Source: Women's Health Weekly (2005-02-03)
|
